
The Brattle Group announced that it has expanded its global reach with the launch of an office in Paris, the economic consultancy’s fifth location in Europe and fourteenth across the globe.
“Paris is an important strategic location for many of our clients,” said Brattle President David Hutchings. “Our new Paris office reflects Brattle’s strong and growing client base in France, and the ever-expanding nature of our global work.”
The Paris office will be jointly led by Principal Carlos Lapuerta, a renowned international arbitration and competition expert who has been with Brattle for more than three decades; and Principal Laurent Eymard, an expert with more than fifteen years of experience with merger, antitrust, and state aid cases before the Autorité de la concurrence, French courts, and other European jurisdictions.
“Brattle is committed to providing exceptional services to our European clients, and our ability to do so is further enhanced with a local presence in a city that is globally recognized as an important hub for arbitration,” said Mr. Lapuerta, who will split his time between Paris and London.
“The Paris market is also characterized by increasingly complex mergers, antitrust investigations, and civil litigations,” added Mr. Eymard, who will split his time between Paris and Brussels. “Our presence here is an ideal complement to our strong global competition team, as we continue to help clients address complex issues in France, across the EU, and worldwide.”
Featured News
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Live Nation Under Criminal Antitrust Investigation Over Pandemic-Era Refund Policies
May 19, 2025 by
CPI
BCLP Strengthens Healthcare and Antitrust Litigation Practice
May 19, 2025 by
CPI
Italy Fines AI Chatbot Maker Replika €5 Million Over Privacy Violations
May 19, 2025 by
CPI
Germany’s Antitrust Chief: EU-US Tech Policy Divide Is Mostly Rhetoric
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas